Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection.

Vascular pharmacology - 1 Jan 2000

Pálóczi J, Szántai Á, Kobolák J, Bock I, Ruivo E, Kiss B, Gáspár R, Pipis J, Ocsovszki I, Táncos Z, Fehér A, Dinnyés A, Onódi Z, Madonna R, Ferdinandy P, Görbe A

Abstract excerpt

INTRODUCTION: Stem cell-derived cardiac myocytes are potential sources for testing cardiocytoprotective molecules against ischemia/reperfusion injury in vitro. MATERIALS AND METHODS: Here we performed a systematic analysis of two different induced pluripotent stem cell lines (iPSC 3.4 and 4.1) and an embryonic stem cell (ESC) line-derived cardiac myocytes at two different developmental stages. Cell viability in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Survival
Share to Myocardial Reperfusion Injury

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myocytes, Cardiac

Share to Nitric Oxide Donors

Share to Oxidative Stress

Share to Pluripotent Stem Cells

Share to Troponin I

Share to Vascular Cell Adhesion Molecule-1

Source

Identifiers

PMID: 32827678
DOI: 10.1016/j.vph.2020.106781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection.PMID 32827678Read ↗

Therapeutic use of stem cells for cardiovascular diseaseSemantic proximity Read ↗

Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype.Semantic proximity Read ↗

Regenerating Damaged Myocardium: A Review of Stem-Cell Therapies for Heart FailureSemantic proximity Read ↗

Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterizationSemantic proximity Read ↗

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity ScreeningSemantic proximity Read ↗

Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived CardiomyocytesSemantic proximity Read ↗

Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem CellsSemantic proximity Read ↗

Functional isolation, culture and cryopreservation of adult human primary cardiomyocytesSemantic proximity Read ↗

Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart DiseaseSemantic proximity Read ↗

Resveratrol promotes differentiation of mouse embryonic stem cells to cardiomyocytes.Semantic proximity Read ↗

Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac MyocytesSemantic proximity Read ↗

Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.